MELANOMA I: Epidemiology – Biology– Diagnostic Imaging

P1 Primary multiple malignant tumors in skin melanomas in Ukraine
S. Korovin, M. Kukushkina

P2 The expression of Galectin-1 in melanocytic nevus, dysplastic nevus and malignant melanoma
J. Yoon, S.-M. Kim, J.-G. Kim, S.-H. Lee, C.-Y. Kim, T.-J. Yoon

P3 The increasing incidence of “thin” melanomas in North Staffordshire: A 10-year analysis
J. Hardwicke, S. Rayatt

P4 Intracellular uptake of liposomal chloroaluminum phthalocyanine and this antitumor activity on 3D melanoma cell culture
P.A. Barbugli, C.P. Alves, E.M. Espreafico, A.C. Tedesco

P5 Polymorphisms in GSTM1, GSTT1, coffee consumption and cutaneous melanoma risk
C. Fortes, S. Mastroeni, F. Melchi, P. Anzidei, L. Innocenzi, R. Giovinazzo, G. Antonelli, P. Pasquini, F. Venazetti

P6 Dermatoscopy: diagnostic value of inversed network in melanoma diagnosis
F. Poffet, E. Khelifa, G. Kaya, F.-A. Le Gal

P7 Clinical in vivo high-resolution multiphoton tomography of human skin for imaging cancer cells, extracellular matrix components, and sunscreen nanoparticles
K. Koenig

P8 Scalp metastatic melanoma «mimicking» blue nevus - Great attention is needed!
M.-G. Trakatelli, K. Kalokasidis, A. Patsatsi, D. Kalabalikis, S. Charalabidis, I. Efstratiou, D. Sotiriadis

P9 Cutaneous and mucosal head and neck melanoma: an epidemiological study
A. Kempele, K. Azarjana, I. Cema, A. Rivosh, D. Pjanova

P10 The contribution of dermoscopy in the diagnostic accuracy of melanoma. Our experience
E. Lazaridou, I. Kyrmanidou, A. Trigoni, C. Fotiadou, C. Giannopoulou, A. Papakonstandinou, D. Ioannides

P11 Dermatooncology in Ukraine – what we have and what is necessary to do
A. Turkevych, O. Syzon

P12 Factors associated with the prevalence of atypical nevi among sun resistant skin phototypes
A. Tosca, K. Lasithiotakis, A. Kokolakis, K. Krasagakis

P13 Anthropometric factors and risk of cutaneous melanoma in a large French prospective cohort study
M. Kvaskoff, A. Bijon, S. Mesrine, F. Clavel-Chapelon, M.C. Boutron-Ruault

P14 Epidemiological and clinical characterization of patients with multiple primary melanomas in a Greek cohort
V. Nikolaou, M. Plaka, D. Polydorou, V. Chasapi, I. Stefanaki, I. Potouridou, E. Hatziolou, E. Kodela, O. Papadopoulos, A. Katsambas, A. Stratigos

P15 Clinical and dermoscopical diagnosis of micro-melanoma
E. Tolomio, F. Crippa, D. Moglia, A. Bono, M. Santinami

P16 In-transit metastase or primary melanoma?
N. Demirkan, I. Gokalan Kara, S. Ergin, H. Tosun

P17 Comparative genomic hybridization (CGH) analysis of a distinct variant of melanocytic nevi, named deep penetrating blue nevi
L. Held, J. Bauer, C. Garbe

P18 Comparative effect of pomegranate extract (PFE) and sodium salicylate (NaSal) on SbCl-1 melanoma cellular proliferation
K. Xenos, M. Katsarou, S. Markantonis, C. Tsimblouli, A. Katsarou, A. Stratigos, A. Katsambas, J. Anastasopoulou

MELANOMA II: Surgery – Staging - Prognosis

P19 Sentinel lymph node biopsy in melanoma
E. Eelma, J. Soplepmann

P20 Electrochemotherapy with bleomycin: a local treatment with possible systemic implication
A. Testori, F. Verrecchia, J. Soteldo, A. Di Pietro, G. Spadola, G.C. Vitali, C. Martinoli, S. Gandini, P.F. Ferrucci

P21 Presentation of multicentric trial about sentinel node identification with sentinella® intraoperative gamma camera Vs traditional gamma probe
A. Testori, F. Verrecchia, J. Soteldo, A. Di Pietro, G. Spadola, G.C. Vitali, F. Cataldo, C. Pari, P.F. Ferrucci

P22 Electrochemotherapy: two years of experience in a cancer center
V. Farricha, H. Vasques, S. Carvalhal, J.C. Mendes de Almeida

P23 Why we should not excise nevi with laser ablation or liquid nitrogen cryotherapy?
D. Kalabalikis, A. Traianou, M.G. Trakatelli, A. Patsatsi, A. Mantas, S. Charalabidis, D. Sotiriadis

P24 Electrochemotherapy: a technique for multiple approaches in the treatment of locally advanced melanoma
V. Farricha, H. Vasques, S. Carvalhal, J.C. Mendes de Almeida

P25 Prognostic value of SLN biopsy in malignant melanoma of the head/neck in comparison to trunk and extremities
F. Schenck, I. Satzger, A. Meier, B. Voelker, A. Kapp, R. Gutzmer

P26a Staging melanoma malignum using high resolution technic
K. Szalai, B. Somlai, J. Harsing, Z. Hatvani, S. Karpati, G. Botlik, P. Hollo

P26b Outcome of sentinel node negative patients with primary cutaneous melanoma - Prognostic factors and survival probabilities
U. Leiter, O. Elsäßer, P.G. Buettner (Australia), F. Meier, G. Metzler, M. Möhrle, H. Breuninger, C. Garbe

MELANOMA III: Medical Therapy

P27 New therapeutic strategies for stage III melanoma
E. Minutilli

P28 Treatment of lentigo maligna with imiquimod: A follow up of 61 patients
M. Baumgartner, R.E. Hunger

P29 New heteroaromatic compounds for a targeted melanoma therapy: factors modulating subcellular distribution
M. Gardette, J. Papon, S. Palle, P. Labarre, E. Noirault, J.C. Madelmont, M. Bonnet, J.M. Chezal, N. Moins

P30 Phase II clinical trial using virus-like particle (VLP) vaccine including a melan-A analogon and imiquimod
S.M. Goldinger, L. Imhof, J. Willers, L.E. French, R. Dummer

P31 NexrutineR: a novel agent for malignant melanoma
R. Ghosh, E. Clark, H. Graham, A. Kumar

P32 Erlotinib in combination with different chemotherapeutics is active in a SCID mouse/human melanoma model
N. Schicher, H. Pehamberger, C. Hoeller

P33 Trends in serum lactate dehydrogenase (LDH) and absolute lymphocyte counts (ALC) correlate with activity of ipilimumab as second line therapy for patients with metastatic melanoma
L. Pierret, S. Wilgenhof, V. del Marmol, D. Roseeuw, B. Neyns

P34 Metastatic melanoma of the brain: pathogenesis and treatment
C. Delimpalta, C. Zampetaki

P35 Status quo of the S3 guideline “Diagnosis, treatment and follow-up of melanoma” in Germany
A. Pflugfelder, C. Czeschik, M. Follmann, C. Garbe, D. Schadendorf

P36 Anti-tumor effects of recombinant human interferon-α and-β on human melanoma cells in vitro
K.-Y. Chung, M.-R. Roh, S.-Y. Rha

P37 Weekly bevacizumab and paclitaxel in patients with metastatic melanoma
D. Bafaloukos, H. Linardou, A. Molfeta, V. Giannopoulos, A. Christopoulou, P. Papakostas, A. Tarampikou, D. Kanaloupiti, A. Bousboukea, M. Panou, K. Petraki

MELANOMA IV: Unusual Presentations

P38 Primary malignant melanoma of the Female Genital Tract (FGT): disease course and therapy concept of a vulva melanoma
A. Al-Rumih, N. Minovarov, F. Meiss, D. Nashan

P39 Giant nodular polypoid melanoma of the neck
Z. Plzakova, I. Krajsova, T. Sukova, I. Prochazkova

P40 Oral mucosa melanoma
V. Oktseloglou, E. Pappa, M. Trakateli, N. Papadogeorgakis

P41 Melanoma of unknown primary site in which a primary site became apparent five years later
S. Lee, H.-J. Lee, S.-H. Oh, Y.-J. Seo, Y. Lee

P42 Pediatric melanomas in the era of sentinel lymph node biopsy
A. Ghaferi, T. Frankel, M. Sabel, V. Cimmino

P43 Melanoma metastatic to the breast: a report of 4 cases
D. Bafaloukos, A. Tarampikou, A. Molfeta, D. Kanaloupiti, K. Bousboukea, V. Giannopoulos, G. Balaska, H. Linardou

P44 Malignant melanoma of the oral cavity
M. Piagkou, G. Piagkos, P. Skandalakis

NMSC I: Epidemiology – Genetics – Clinical Aspects

P45 Erythroplasia Queyrat s.Bowen disease of the glans penis
M. Milosavljevic, L.J. Spalevic, N. Blazevic-Kamenov, D. Pivac-Marinkovic, D. Ljubisavljevic

P46 Retrospective study of 70 patients with NMSC
E. Vasili, E. Shkodrani, D. Harja, L. Labinoti, A. Zoto

P47 Pigmented basal cell carcinoma masquerading as malignant melanoma – case report
B. Spasic, J. Bandic, Z. Ceranic, G. Stanojevic, M. Al Junidi, M. Paravina

P48 Cyclins D1, E and A expression in squamous cell carcinoma
J. Stojkovic-Filipovic, D. Brasanac, D. Skiljevic, L. Medenica

P49 A 33-year-old woman with nevoid basal cell carcinoma syndrome presenting with multiple nodular, nodulocystic, ulcerating and superficial basal cell carcinomas predominantly localized in the head and neck region. Case report and review of therapeutic options
L. Vandebuerie, E. Legius, V. Thijs, M. Stas, P. Wolter, J. Van den Oord, M.Garmyn

P50 TGF-β-509 C allele and CC genotype is associated with susceptibility to Basal Cell Carcinoma
S.H. Vakili, A. Kookhaei, R. Salmanpour, S. Naeimi, N. Erfani, A. Ghaderi, F. Handjani

P51 Validity of ultrasonography in diagnosing of pre-cancer and neoplastic skin lesions: verification of clinical diagnosis and estimation before surgical procedures
M. Maj, E. Szymanska, M. Majsterek, J. Litniewski, E. Piekarczyk, J. Sicinska, M. Slowinska, A. Nasierowska-Guttmejer, A. Nowicki, L. Rudnicka

P52 Inability of dermoscopy to differentiate early-stage squamous cell carcinoma from keratoacanthoma
G. Chaidemenos, Z. Apalla, A. Trigoni, T. Koussidou, G. Karakatsanis

P53 Basal cell carcinoma in the Netherlands: how often do they occur?
S.C. Flohil, E. de Vries, J.W. Coebergh, T. Nijsten

P54 Vitamin D-binding protein polymorphisms are not associated with development of (multiple) basal cell carcinomas
S.C. Flohil, E. de Vries, J.B.J. van Meurs, Y. Fang, B.H.Ch. Stricker, A.G. Uitterlinden, T. Nijsten

P55 Cutaneous squamous cell carcinoma (SCC) of the head and neck: risk factors of overall and recurrence-free survival
E. Vakirlis, T.G. Tzellos, A. Lallas, A. Kyrgidis, A. Patrikidou, P. Xirou, K. Kitikidou, E. Bourlidou, K. Vahtsevanos, K. Antoniades

P56 A potential role of codon 1315 polymorphism of PTCH in a “numerous for the age” basal cell cancers
N. Wikonkal, R. Farkas, A. Banvolgyi, D. Haluszka, A. Blazsek, J. Harsing, S. Karpati

P57 Risk factors associated with large size of squamous cell carcinoma of the skin
C. Renzi, S. Mastroeni, T. Mannooranparampil, F. Passarelli, A. Caggiati, P. Pasquini

P58 Early-onset basal cell carcinoma
D. Skiljevic, J. Stojkovic-Filipovic, M. Nikolic, L. Medenica

P59 Poly(ADP-ribosylation) and chromatin assembly factor-1 influence chromatin replication and biological aggressiveness of skin and mucosal squamous cell carcinomas of the head and neck
M. Siano, M. Mascolo, G. Ilardi, L. Nugnes, M.A. Vecchione, G. de Rosa, S. Staibano

P60a In vivo histologic diagnosis of basal cell carcinoma by means of confocal microscopy
C. Longo, M. Manfredini, A. Casari, P. Pepe, G. Pellacani

P60b Epidemiological trends in non melanoma skin cancer in a Mediterranean population
A. Pulido, J.M. Bellón, F. Carretero, P. Borregón, N. Cano, C. Ceballos, I. Longo

NMSC II: Surgical – Medical Management

P61 Topical treatment of actinic keratoses with low dose 5-fluorouracil in combination with salicylic acid
M. Schlaak, J.C. Simon

P62 Pre-clinical pharmacological and skin penetration profile of LDE255, a novel and specific Smoothened antagonist
F. Kalthoff, A. Billich (Switzerland), H. Aschauer, M. Dorsch, J. Kelleher, J. Meingassner, S. Pan, B. Wolff-Winiski, X. Wu, A. Stuetz

P63 Effect of pomegranate extract (PFE) in human radiodermatitis patients with squamous cell carcinoma (SCC) after radiotherapy
K. Xenos, N. Koliarakis, S. Markantonis, N. Protopapa, O. Flyessa, A. Katsarou, A. Tanga, A. Stratigos, A. Katsambas

P64 The subclinical extension of basal cell carcinoma following preoperative laser procedures
A.-Y. Cho, S.-S. Lee, Y. Lee, J.-H. Lee, Y.-J. Seo

P65 Recurrent morpheaform basal cell carcinoma after surgical excision
S.-S. Lee, Y.-J. Kim, J.-H. Lee, Y.-J. Seo

P66 Successful treatment of metastasizing squamous cell carcinoma with cetuximab
M. Alter, B. Volker, A. Kapp, R. Gutzmer

P67 Flap reconstruction of nose defects after cancer excision
G. Defterevos, S. Balasis, G. Mitsala, A. Mikrova, M. Rapanou, D. Tsiliboti

P68 Τotal nasal reconstruction using a prelaminated free radial forearm flap and porous polyethylene implanτs
D. Tsiliboti, D. Antonopoulos, G. Mitsala, A. Mikrova, G. Defterevos, S. Balasis, M. Rapanou, I. Christoforou

Photodynamic Therapy

P69 Does the fluence rate influence clinical outcome and pain experienced by the patients with actinic keratosis treated with PDT?
Z. Apalla, D. Panagiotidou, D. Ioannides, E. Sotiriou

P70 Which light dose is the optimal for treating actinic keratosis with PDT? An intraindividual randomized comparative study
Z. Apalla, D. Panagiotidou, D. Ioannides, E. Sotiriou

P71 Choosing an alternate light source with a corresponding dose in photodynamic therapy (it’s not rocket science, but it is quantum physics!): determining the PPIX activiation effect
R.M. Sayre, D. Pariser, D.J. Goldberg, R. Geronemus, R.W. Gottschalk, J.D. Dowdy

P72 Topical photodynamic therapy using combination of laser ablation with GaAs laser 980nm for nodular basal cell carcinomas. One-year follow-up study
J. Lippert, R. Šmucler, P. Arenberger

Malignant And Other Skin Tumors

P73 Skin metastatic tumor originated from internal carcinoma. A rare case report
E. Toumbis-Ioannou, I. Panayiotides, K. Triantafyllou, S. Giatrakou, K. Tzima, N.G. Stavrianeas

P74 Resurfacing the penoscrotum with local pedicle flaps at large defects after ablation of penoscrotal extramammary Paget’s Disease
S.-H. Oh, S.-S. Lee, Y.-J. Seo

P75 Extraocular sebaceous carcinoma treated with wide excision and island flap
S.-H. Oh, S.-S. Lee, Y.-J. Seo

P76 Rapidly growing angiosarcoma of the face successfully treated with radiotherapy
S. Gkalpakiotis, P. Arenberger, M. Arenbergerova

P77 Skin as a target - primary tumors and metastasis
V. Mikulic, F. Ser, S. Obradovic

P78 A case report of indeterminate cell histiocytosis (ICH) in an adolescent female patient
E. Lazaridou, C. Giannopoulou, C. Fotiadou, E. Vakirlis, I. Papagaryfallou, D. Ioannides

P79 Successful treatment of extramammary Paget΄s disease with topical imiquimod
M. Schmid, U. Zierhofer-Tonar, A. Seeber, B. Volc-Platzer

P80 Necrolytic erythema without glucagonoma with hepatitis C
R. Filippetti

P81 Synovial sarcoma of the lumbar spine
D. Tsiliboti, S. Balasis, G. Mitsala, A. Mikrova, G. Defrerevos, D. Antonopoulos

P82 Infiltrating apocrine adenocarcinoma of the groin associated with extramammary paget’s disease
S.-H. Seo

P83 Ulcus terebrans - a case report
D. Pivac-Marinkovic, M. Milosavljevic, D. Ljubisavljevic, M. Stojiljkovic, N. Blazevic-Kamenov

P84 Peutz-Jeghers syndrome-cutaneous manifestations-case report
N. Syrmos, P. Isaakidis, V. Tsirpanlis, K. Paltatzidou, F. Chatzinasiou, S. Tzinas

P85 Facial erysipelas in immunologically altered patients - two cases report
N. Syrmos, P. Isaakidis, V. Tsirpanlis, K. Paltatzidou, F. Chatzinasiou, S. Tzinas

P86 Syringocystadenoma Papilliferum
A. Yorukoglu, N. Demirkan, L. Tasli, U. Koltuksuz

P87 Malignacies appearing as skin ulcers
E. Agiasofitou, N. Zakopoulou, F. Liordou

P88 Case report - Extramammary Paget disease
R. Carvalho, V. Macias, A. Rodrigues, A. Afonso, J. Cardoso

P89 Distinction of two different primary Merkel cell carcinomas in one patient by Merkel cell polyomavirus (MCPyV) genome analysis
A. Thiemann, D. Schrama, R. Houben, K.C. Kähler, A. Hauschild, J.C. Becker

Kaposi’s Sarcoma

P90 Remission of iatrogenic Kaposi`s sarcoma after switch of immunosuppressive regimen to everolimus in a patient with myasthenia gravis
S. Krengel, I. Satzger, B. Volker, A. Kapp, R. Gutzmer

P91 Clearance of non AIDS-Kaposi sarcoma after removal of coexistent clear cell renal cell and chromophobe renal cell carcinomas
S. Giatrakou, V. Leodara, A. Siatelis, E. Papadavid, K. Theodoropoulos, K. Safioleas, M. Stamatakos, N.G. Stavrianeas

P92 Kaposi Sarcoma in renal transplant patients
B. Somlai, G. Vegso, A. Tσth, R. Langer

P93 Kaposi’s Sarcoma associated with severe thrombocytopenia
G. Avramidis, K. Krasagakis, A. Tosca

P94 Kaposi Sarcoma - presenting without cutaneous manifestations - unusual case report
N. Syrmos, C. Iliadis, K. Grigoriou, G. Gavridakis, K. Paltatzidou, F. Chatzinasiou, D. Arvanitakis

Sun Protection

P95 Comedogenicity and cosmetic acceptability of a new UVA/UVB protection cream
F. Sidou, N. Kerrouche, P. Soto

P96 Hydration potential of a new UVA/UVB protection cream
S. Brocard, F. Sidou, N. Kerrouche, P. Soto

Cutaneous Adverse Effects And Targeted Treatments

P97 Follicular and cystic eruptions under sorafenib therapy
A. Degen, F. Schenck, B. Voelker, A. Kapp, R. Gutzmer

P98 Weekly pulses of oral azithromycin for the treatment of EGFRIs related papulopustular eruption
V. Nikolaou, A. Strimpakos, A. Stratigos, C. Antoniou, A. Katsambas, K. Syrigos

Cutaneous T-Cell Lymphoma

P99 Broadband UVA versus PUVA in the treatment of early stage mycosis fungoides: a comparative study
M. Fawzi, M. El Mofty, S, Ramadan, R. Hegazy, S. Sayed

P100 Primary cutaneous peripheral T-cell lymphoma, unspecified: a case report
E. Papadaviv, P. Tsirigotis, S. Giatrakou, T. Papadaki, C. Theodoropoulos, I. Panagiotides, P. Foukas, E. Nikita, J. Dervenoulas, N.G. Stavrianeas

P101 Subcutaneous panniculitis-like T-cell lymphoma arising in localised scleroderma. Case report
A. De Coninck, C. Heughebaert, J.-P. Hachem, T. Roelandt, D. Roseeuw

P102 Vorinostat and narrowband ultraviolet B phototherapy in a patient with mycosis fungoides: no evidence for phototoxicity
L. Imhof, S.M. Goldinger, L.E. French, R. Dummer

P103 Primary cutaneous mantle cell lymphoma
E. Zattra, R. Zambello, F. Marino, M. Bordignon, M. Alaibac

P104 Large B-cell lymphoma, leg type - a rare lymphoma case report
A. Patsatsi, K. Panteliadou, M.G. Trakatelli, D. Kalabalikis, V. Karavasilis, I. Efstratiou, D. Sotiriadis

P105 Mycosis fungoides or coexistence pemphigus and mycosis fungoides
D. Ninković, A. Prtina, G. Popović, D. Brdanin, M. Celić

P106 Mycosis fungoides with a CD56+ immunophenotype: report of 2 cases
V. Nikolaou, L. Marinos, A. Stratigos, A. Economidi, T. Papadaki, A. Katsambas, C. Antoniou

P107 Clinical, immunophenotypical and molecular analysis of a series of patients with poikilodermatous mycosis fungoides
V. Nikolaou, A. Economidi, A. Stratigos, L. Marinos, A. Miniati, T. Papadaki, A. Katsambas, C. Antoniou

P108 Oral manifestations of cutaneous T-cell lymphoma
G. Piagkos, M. Piagkou, P. Skandalakis

P109 Nodular cutaneous melanoma associated with mycosis fungoides
M. Milinkovic, K. Karadzic, L. Medenica